Is Neko Health’s body scan worth it? Spotify billionaire’s startup has come to America

The Preventative Health Gold Rush

Daniel Ek, the man who rebuilt the music industry, is now trying to rebuild your body. Or at least, he wants to scan it. His latest venture, Neko Health, has pulled in $700 million to deploy high-tech scanning pods that look like something out of a mid-budget sci-fi film. The goal is simple on paper: find problems before they become catastrophes. But for those of us building in the tech space, the narrative here is less about the healthcare and more about the data play.

We are seeing a massive influx of capital into the preventative diagnostics sector. It is not just Ek. Midjourney, an AI powerhouse known for art, is pivoting into hardware for body scanning. Function Health is raising big numbers to build platforms that aggregate this data. When the big money starts flowing toward the same specific mechanical problem—in this case, mapping the human biology at a granular level—it means the industry is betting that the old medical model is finally ready to break.

The Founder's Dilemma: Prevention vs. Friction

From a founder's perspective, preventative health is a nightmare to sell. Most people don't want to think about their health until it fails. Insurance companies are traditionally built on reactive care, not proactive optimization. So, how does Neko Health justify a $700 million valuation? They aren't just selling scans; they are building a proprietary dataset that currently doesn't exist in a unified format.

If you go to a hospital today, your data is fragmented. Your blood work is in one portal, your imaging is in another, and your wearables are on your phone. None of them talk to each other. Ek is applying the Spotify model to the human body: aggregate everything, make it searchable, and use AI to find the patterns. The friction, however, is the hardware. Building physical pods that require humans to walk into a room is a massive bottleneck compared to software. It’s a bold move, but it’s high-risk in a way that pure AI startups aren't.

Why Midjourney is Getting Involved

It sounds strange at first—an image generation company building medical hardware. But if you look at what Midjourney actually does, it makes sense. They are masters of computer vision and spatial reconstruction. A body scan is essentially a complex 3D rendering problem. They aren't looking to become doctors; they are looking to own the visual processing layer of the medical industry.

This is a signal for builders. You don't have to be a biotech expert to enter this space. If you understand how to process large amounts of visual data or how to build secure, interoperable databases, there is a massive seat at the table for you. The "health" part is just the use case. The "tech" part is where the actual value is being built.

The Crypto and AI Intersection

Here is where it gets interesting for the STKR community. When you have $700 million companies scanning bodies, you have a massive privacy and ownership problem. Who owns that scan? If Neko Health discovers a rare genetic marker in your skin, do they own the rights to that data for research? This is where decentralized identity and blockchain come in, though the current batch of startups rarely mentions it.

We are heading toward a collision between bio-data and sovereign ownership. I suspect the next generation of these companies won't just be about the scanner, but about the vault where the scan is kept. Builders should be thinking about how to create "Zero-Knowledge" health platforms where a user can get a Neko scan, have an AI analyze it for cancer, and never actually reveal their identity to the provider.

The Skeptic's View

I’ve seen plenty of "Uber for X" or "Spotify for Y" startups fail because they underestimated the regulatory moat. Healthcare is not music. You can't just move fast and break things when you're dealing with FDA approvals and patient liability. Neko Health coming to America is a massive test of whether a tech-first approach can survive the US medical bureaucracy.

Investors are betting big because the upside is the entire human lifespan. If you can become the dashboard for a billion lives, you aren't just a unicorn; you're the infrastructure of the future. But for every Neko, there are a dozen hardware startups that will die in the logistics of the real world. Physical hardware doesn't scale like a GPT model.

The Takeaway for Builders

If you are looking at this space, don't try to build the next scanner. That’s a billionaire’s game involving massive capital and specialized manufacturing. Instead, look at the layers underneath. Look at the data interpretation, the privacy protocols, and the integration tools that will connect these scans to the rest of the patient’s life.

• Infrastructure over Hardware: The hardware is the bait; the data ecosystem is the hook.
• Visual AI is the Driver: The core tech here is computer vision, not just biology.
• Privacy is the Next Battleground: As these scans become more common, the demand for decentralized data ownership will skyrocket.

Daniel Ek is betting that we want to know what’s happening inside us before it hurts. He’s probably right. But the real winners won't just be the ones with the best cameras; it will be the ones who build the most trusted way to handle that information. Stay skeptical of the hype, but pay very close attention to the data silos being built.

Read the original at TechCrunch Startups →